← Back to screener

RXO, Inc. RXO

Rank #2081 · NYSE · $4.5B market cap
Audited by Deloitte & Touche LLP, no going-concern flag in the latest filing.
Score
34.5
P/E
1133.4
P/B
7.72
ROE
0.7%
Op. Margin
1.0%
Debt Ratio
482%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★★☆☆☆
Weak

P/E 1133.4x, P/B 7.72x. Ranks in the top 70% of the universe.

Profitability ★★☆☆☆
Weak

ROE 0.7%. Ranks in the top 68% of the universe.

Safety ★☆☆☆☆
Weak

Debt ratio 482%. Ranks in the top 79% of the universe. Above 200% signals meaningful leverage risk.

Growth ★☆☆☆☆
Poor

Revenue decline of 18.1% year over year. Ranks in the top 90% of the universe.

Valuation is the relative strength · Safety is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2022$3.4B$0.1B$0.0B$1.0B1.8111
2023$4.7B$0.2B$0.1B$1.1B4.190
2024$4.8B$0.1B$0.1B$1.1B2.671
2025$3.9B$0.0B$0.0B$0.6B1.0482

← See the full screener